Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Immunol ; 212(11): 1680-1692, 2024 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-38607278

RESUMO

Plasmacytoid dendritic cells (pDCs) are strongly implicated as a major source of IFN-I in systemic lupus erythematosus (SLE), triggered through TLR-mediated recognition of nucleic acids released from dying cells. However, relatively little is known about how TLR signaling and IFN-I production are regulated in pDCs. In this article, we describe a role for integrin αvß3 in regulating TLR responses and IFN-I production by pDCs in mouse models. We show that αv and ß3-knockout pDCs produce more IFN-I and inflammatory cytokines than controls when stimulated through TLR7 and TLR9 in vitro and in vivo. Increased cytokine production was associated with delayed acidification of endosomes containing TLR ligands, reduced LC3 conjugation, and increased TLR signaling. This dysregulated TLR signaling results in activation of B cells and promotes germinal center (GC) B cell and plasma cell expansion. Furthermore, in a mouse model of TLR7-driven lupus-like disease, deletion of αvß3 from pDCs causes accelerated autoantibody production and pathology. We therefore identify a pDC-intrinsic role for αvß3 in regulating TLR signaling and preventing activation of autoreactive B cells. Because αvß3 serves as a receptor for apoptotic cells and cell debris, we hypothesize that this regulatory mechanism provides important contextual cues to pDCs and functions to limit responses to self-derived nucleic acids.


Assuntos
Autoimunidade , Células Dendríticas , Integrina alfaVbeta3 , Lúpus Eritematoso Sistêmico , Camundongos Knockout , Transdução de Sinais , Receptor 7 Toll-Like , Animais , Camundongos , Células Dendríticas/imunologia , Integrina alfaVbeta3/imunologia , Integrina alfaVbeta3/metabolismo , Autoimunidade/imunologia , Receptor 7 Toll-Like/imunologia , Receptor 7 Toll-Like/metabolismo , Receptor 7 Toll-Like/genética , Lúpus Eritematoso Sistêmico/imunologia , Transdução de Sinais/imunologia , Camundongos Endogâmicos C57BL , Citocinas/metabolismo , Citocinas/imunologia , Receptor Toll-Like 9/imunologia , Receptor Toll-Like 9/metabolismo , Linfócitos B/imunologia , Autoanticorpos/imunologia , Glicoproteínas de Membrana/imunologia , Glicoproteínas de Membrana/metabolismo , Ativação Linfocitária/imunologia , Modelos Animais de Doenças
2.
J Immunol ; 205(7): 1810-1818, 2020 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-32859730

RESUMO

Systemic lupus erythematosus (SLE) is defined by loss of B cell tolerance, resulting in production of autoantibodies against nucleic acids and other cellular Ags. Aberrant activation of TLRs by self-derived RNA and DNA is strongly associated with SLE in patients and in mouse models, but the mechanism by which TLR signaling to self-ligands is regulated remains poorly understood. In this study, we show that αv integrin plays a critical role in regulating B cell TLR signaling to self-antigens in mice. We show that deletion of αv from B cells accelerates autoantibody production and autoimmune kidney disease in the Tlr7.1 transgenic mouse model of SLE. Increased autoimmunity was associated with specific expansion of transitional B cells, extrafollicular IgG2c-producing plasma cells, and activation of CD4 and CD8 T cells. Our data show that αv-mediated regulation of TLR signaling in B cells is critical for preventing autoimmunity and indicate that loss of αv promotes escape from tolerance. Thus, we identify a new regulatory pathway in autoimmunity and elucidate upstream signals that adjust B cell activation to prevent development of autoimmunity in a mouse model.


Assuntos
Linfócitos B/fisiologia , Integrina alfaV/metabolismo , Lúpus Eritematoso Sistêmico/imunologia , Glicoproteínas de Membrana/metabolismo , Receptor 7 Toll-Like/metabolismo , Animais , Autoanticorpos/metabolismo , Autoimunidade , Células Cultivadas , Modelos Animais de Doenças , Humanos , Imunoglobulina G/metabolismo , Imunomodulação , Integrina alfaV/genética , Ativação Linfocitária , Glicoproteínas de Membrana/genética , Camundongos , Camundongos Transgênicos , Receptor 7 Toll-Like/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA